CH
HCAT icon

CVS Health’s Health Catalyst HCAT Stock Holding History

CVS Health’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,273
Closed -$77.1K – 34
2025
Q4 		$77.1K Hold
32,273
– – 0.06% 8
2025
Q3 		$92K Hold
32,273
– – 0.09% 3
2025
Q2 		$122K Hold
32,273
– – 0.06% 3
2025
Q1 		$146K Hold
32,273
– – 0.08% 3
2024
Q4 		$228K Hold
32,273
– – 0.1% 3
2024
Q3 		$263K Hold
32,273
– – 0.11% 5
2024
Q2 		$206K Hold
32,273
– – 0.1% 5
2024
Q1 		$243K Hold
32,273
– – 0.11% 5
2023
Q4 		$299K Hold
32,273
– – 0.15% 5
2023
Q3 		$327K Hold
32,273
– – 0.17% 7
2023
Q2 		$403K Hold
32,273
– – 0.21% 7
2023
Q1 		$377K Hold
32,273
– – 0.22% 7
2022
Q4 		$343K Hold
32,273
– – 0.3% 5
2022
Q3 		$313K Hold
32,273
– – 0.3% 6
2022
Q2 		$467K Hold
32,273
– – 0.39% 5
2022
Q1 		$843K Hold
32,273
– – 0.57% 5
2021
Q4 		$1.28M Buy
+32,273
New +$1.47M 1.12% 3

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CVS Health's HCAT Position: Q1 2026 in Review

CVS Health sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 32,273 shares — an estimated $77.1K sold.

CVS Health first reported a position in HCAT in Q4 2021 and held it in 17 quarters. The position peaked at $1.28M in Q4 2021. 131 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • CVS Health reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • CVS Health sold 32,273 Health Catalyst shares in Q1 2026, an estimated $77.1K.
  • CVS Health first reported a position in Health Catalyst in Q4 2021 and held it in 17 quarters.
  • CVS Health's Health Catalyst position peaked at $1.28M in Q4 2021.
  • 131 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on CVS Health's 13F filing for Q1 2026, filed 7 May 2026.